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HISTORY OF BLOOD TRANSFUSION
The history blood transfusion is among the most
fascinating, interesting, 1.1nusual and romantic part ot
medical history.

There is probably no other therapeudio

measure in the whole range of medical soienoe whioh has
waxed and wanned with such extremes in medical usage.
The idea that blood contained the vital essence of life
is almost as old as medicine itself.

There is

ab~ndant

evidence in the ancient belief in the t.lse of blood as a
remedy, the idea being that healthy blood should be used
as a potion tor the treatment of various ills (70).

And

likewise the degrading etteots ot the abuse of blood in
oases of perversion (20}.
Historical beliefs regarding the efteots of blood:
Pliny about 50 A.D. tells of the drinking of the
blood of dying gladiators in the arena "'as if ot.lt ot
living oups,"' tor epilepsy; that "'a man's own blood
rubbed upon himself will relieve pain;"' and that the
Egyption kings used baths of blood for the oure ot
elephantiasis.

Galen about 200 A.D. advised the drink-

ing of blood for the oure of various diseases, particularly epilepsy (20, 70).
One who drinks menstrual blood or the blood of a
leper Will act as a lunatio, will be sexually uncontrolable and generally evil.

The antidote is to eat surpents

whose heads and tails h:ive been removed in the proper

manner.

There were numerous, many not without humor,

of the uses ot oata, doves, turtles and other animals'
blood in various mixtures for treatment, especially
epilepsy.

or

one girl, an epileptic, is mentioned, who

atter taking oat's blood acted like a oat.

It a blaok

oat's tail be out off at the distal third, and the first
three drops of blood given to an epileptic, it will act
towards a oure; the blood from a wild oat should be even
better.

The blood trom the ear of a blaok oat should

be of value in the treatment of erysipelas.

The drink-

ing of blood of a weasel or of a dog for the bite ot a

rabid animal was well recommended.

The mixed blood of

turtles, seals and man was used for the treatment ot
epilepsy, fits and scurvy among the Norwegians, and that
of the reindeer in Lapland.

Mixed blood trom kids, geese

and ducks was used tor diseases affecting the spirits.
The flowing blood from the wounded soldiers was saved and
drunk as a remedy.

People would rush into the arena and

drink the fresh flowing blood of the wounded and dying
gladiators.

Distillates from the blood were employed

with other distillates of even ver:y obnoxious substances
as the human bowel excreta for the remedy of many diaeasea.
The blood was thought to contain various spirits and so
it was used to treat oases that were thought to be due to
the maladjustment ot these mythical tactors in the hope

·"'

that it would restore the derangement (20).

Veneseotion onoe a very oommon practioe:
This historical comment would be incomplete and
would leave a f'alse impression if blood
not mentioned.

letting was

Bleeding has a prehistoric origin and

may have arisen from the relief afforded by menstruation,. nose bleed, and bleeding from piles ( 135).

'rbe

rational was that bleeding with the copious forcing ot
water washed and cleansed the blood (45, 57).

Hippoorates

460 B.C. advised it for hypochondria, gas dyspnea, pain
in the ohest, flushing of' the face, apoplexy, epilepsy,
and

~diseases

oonneoted with collection of the humors",

palpitation, livid sputa, quinsy, ·raver, and over filling
of' the

sto~aoh.

Celsus about 25 A.D. recognized that a

patients strength sho,1ld be oonsi dered; and that a patient
with a high f'ever should not be bled.

Galen about 200

A.D. recommended quantitative blood letting, from 200 to
500 oo in the. average oase.

He i nareased the number or

diseases tor which blood letting was used.
bably upon his authority that
almost every ailment (45).

~t

It was pro-

was extended later to

Bleeding beoame the fashion,

oarried on withe.it reason onoe a year.

Not only by the

medioal profession, b1.1t by the barbers and the tenders
of public bath houses.

Excessive blood letting glasses

were handed down from family to family as treasured heirlooms.

Some of the physicians bled their patients moder.
ately, others bled them severely and repeatedly; and then

because the patient :felt taint and weak and his p11lse
was rapid and weak, he was still bled again (45, 57).
The :t'aot is the first hum.an trans:t'usion was performed
on a boy who was exhausted from repeated veneaeotion
(158).

A verse exaggerating the tendency to bleed with

other procedures:
"When patients to me apply,
.I purges, bleeds, and aweats •em:
It a:t'ter that they choose to die,
1Jhat•s that to me? I let's em."
..

Our own General George

Washingt~n

died from loss ot

blood at his physicians' hands (45)•
Tranatllsion without authentic support:
The old Egyptian writings reter to blood transfusion as a

prooed~re

to be used as a means ot medi-

oa tion tor the kings and pr1Dces (54).

Herophilus;

the great Alexandrian anatomist speaks o:t' blood trana:t'usion.

It was condemned by Pliny and Celsus (42).

A

jewish physician in 1492 took blood from three boys tor
Pope Innocent VIII.

There is some doubt as to whether

the transfusion was done.

It is thought that a drought

was made for the Ponti:t't but he and the boys all died
(34, 57}.

Cardemes in 1556 ottered to redeem the un-

regenerate by transfusion of blood from the virtuous.
Andreas Libavius describes a blood tro.nstusion before
Harvey's discovery ot the
was 1613 to 1616 (20, '10}.

oiro~lation

ot the blood which

In his description ot the

prooedu.re, he tells how the blood :rrom a strong healthy
rob1.1st young man may be transferred with two silver
tu.bes to the vessels of a thin, emaoiated, weakened old
man hardly able to oontain his own soul, giving him
life and strength.

Then he cautions that the yo1.1ng man

be given good oare and food so that he will not su.tfer.
But writers refer to this reterenoe as ironical and doubt
it Libavi.is ever saw or ever did a transfusion (20, 70).
The first blood transtusion has been aooredited to
Franoesoo Foil!, a Florentine physician, in 1654•

He used

a silver tube in the artery of the donor and a oann1.1la

in the vein of the recipient, oonneoted by a hollow pipe
made from a blood vessel from an animal.

About the same

time, a monk of Cluny demonstrated the possibility of
intravenous trans:rusion using two silver tubes connected
by a leather ball and oontaining valves so that the
·quantity of blood oould be measured (20, 70).

But these

do not have authenticated reoords (57).
The first authentio blood tranfusions:

The first a1.1thentioated blood

transf~sion

was per-

formed in England by Riohard Lower trom dog to dog.

In

1665 he gave a demonstration of the procedu.re before the

Royal Sooiety in London, uniting an artery of one dog
to a vein or another by means of two q1.1ills or silver

tabes (20, 70, 158).

jean Baptiste Denys or Denis of Montpelliar,
physician to King Louis XIV, is given the honor ot the
first transfusion to man (20, 70, 158).
· injected the blood of a oalf

In 1667, he

or lamb into the veins

of a youth, somnolent and listless from loss ot blood
by

repeated veneseotion.

improved and recovered.

The patient became greatly
About this time, he transfused

a well man with 20 ounces or blood from a lamb after
having bled him ot 10 ounces.
results.

The man suttered no bad

Denys performed the procedure a third time;

this time on a moribund patient who died a few hours
later.

His fourth transtusion was performed on an in-

sane person and repeated twice.

Following the seoond

transfusion "his arm became hot, the pulse rose, sweat
burst out over his forehead, he complained ot pain in
his kidneys and was siok to his stomach.

The next day,

the urine was very dark, in tact

Following the

black.~

third transtusion which was given at his wite's request,
he died.

Denys was tried tor murder but exonerated.

But was with.strained from further transfusions on h11D1ans
e:xoept by the approval of the taoulty ot medioine ot
Paris, who were in opposition to blood transfusion. (158)
Lower in November 1667 transfused a siok man, Cogo,
from a sheep; he died probably from oomplete hemolysia
(20, 70).

Aooording to

~immerman

& Howell, the trans-

rusion performed by Lower in November 1667 was suooessf'ul and was also repeated successf'ully on the same
patient (158).

Due to the tatalies following blood

transtusion, public opinion became against the procedure
and as a resiJ.lt the law of France and England prohibited
it on hwnans; and the Pope in 1678 gave an ediot prohibiting it.

So the practice tell into oblivion tor

about the next century and a hal:f (20• 70, 158).

Germany

and Italy both had their experimenters, but the procedure
likewise was discontinued in both places (158).
About 150 years later, interest was agdin aroused
in blood transtusion.

In 1792 at Eye in Sultolk a Dr.

Russell transfused the blood or two lambs into a boy
suffering trom hydrophobia and tne recovery of' the boy
was attributed to the transfusion.

In 1796 Erasmi1s

Darwin advised transfusion tor "piJ.trid f'ever",
ot the esophagus and oases ot malnutrition.

oanoer

He suggested

the use ot goose quills oonneoted by a short ohioken•a
gut.

There is no record that he followed his own advice

(70) •
.Tames Blundell, an Englishman, in 1818 published
his suocesstul experiments on transfusion following
hemorrhage by the use

or

syringe with a three way stop-

cock; and of air injection in dogs - it required five

drams of air in a very small dog to even cause any etteot
(14).

He was the first to

transt~se

blood from human to

htuaan and to show the value or this prooedu.re in
hemorrhage (158).

In 1820, he stated n•that trans-

fusion by syringe is a :feasible and useful operation,
and that after undergoing the usual ordeal of negleot,
opposition and ridicule, (t will hereafter be admitted
into general praotice.n' {70)

The great diffioulty in

the use of the operation was the ooagulation of the
blood.

Bisohoff in 1835 tried to overoome this by the

use or defibrinated blood as did others {70).
Martin or Berlin 1859

p~blished

records or 57

transfusions, 43 of which were successful.

The fatali-

ties were thought to be due to air embolism,. btlt were
more likely the result of incompatibility.
varied apparatuses were devis•d.

Ma11y and

Higginson 1857 added

the rubber syringe with ball valves {70}.

Braxton

Riots in 1868 attempted to prevent blood ooagulation
with sodium. phosphate (158).

A SUDllllary made by the

obstetrical society ot London 1873-74 showed the results on the whole discouraging.

Blood transfusion

was used when the patient was "in extremisn and animal
transfusion whioh was still used hampered asepsis.
Karst and Highmore 1874 proposed the subcutaneous injection ot defibrinated blood (70 & 158).
Discovery of the blood groups:
Landois observed agglutination and hemolysis 1875
and explained hemogl-ol>lhuria on that basis following

blood transfusion (57).
Probably the most outstanding work contributed
toward blood transfusion was the work of Landsteiner in
1900 9 and ot Shattook independently, demonstrating the

presence ot !so-agglutinins and iso-agglutinable substances in the human red blood corpuscles.
great step was made by jansky in 1907.
all human blood talls into tour groups.
pointed

o~t

The next

He showed that
Hektoen in 1907

the danger of !so-agglutination in the

transfusion of blood.

Moss 1910 confirmed jansky's work

and added that iso-hemolysis ot red.cells follows previot1s agglutination, but that agglutination may ooour
without hemolysis (70, 158).

Ottenberg in 1908 developed

clinioal tests tor blood typing and applied olinioal tests.
to human blood transfusion (158}.
The development ot teohnio:
The injection of normal saline solution in 1875 to
1880 almost oompletely replaced blood transfusion.

vessel surgery was improved;

~nd

Blood

petrolatum and paraffin

coated vessels and syringes to prevent coagulation decreasing the danger of blood transfusion about 1900 (158).
Curtis and David in 1911 used parattin coated
and syringe.

Y-tube

Two years later KimptQn and Brown intro-

duced the Kimpton-Brown paraffin coated tube.

The same

year, 1913, Lindeman revived the multiple syringe method

ot Ziemessen 1892.
revived.

The Blundell method ot 1818 was

Unger in 1915 devised a four-way valve syringe

attachment~

in which the outlets to the donor and reci-

pient were alternately oonneoted with the syringe and
with a reservoir of saline or citrate solution.

Many

modifications have been made of these instr·i.1.tD.ents,
notably are those or Bernheim, janes and Soanell (?O, 158).
The use ot antiooagulat•nta:
The blood clotting in the instr11ments still caused
trouble.

Detibrinated blood had been tried and abandoned.

Braxton Hicks 1868 had tried unsuooessfully to use sodium
phosphate to prevent coagulation; Landois in 1892 recommended the use of hirudin, but the narrow range between
the toxic and the effective dose prevented the adoption
ot it.

Hustin ot Belgium in 1913 introduced the use ot

sodium citrate as an anticoagulant.

The first trans-

fusion with it was done byAgote or Buenos Aires November,
1914.

Lewisolin improved the sodium. citrate teohnio ot

blood tranatusion.

The knowledge of blood transfusion

became universal following its

introd~otion

the great wars in 1917 by Ameriaa•

and use in

(20, 70, 158)

THE FOUR BLOOD GROUPS AND ISO-AGGllJTINATION

The normal human red blood oells form an even

suspension when mixed with normal saline.

Mixing the

serum or the same individual or that of a person of
the same blood group has no reaction on the suspension,
but if seru.m ot an inoompatible blood is mixed with this
suspension clumping of the cells or agglutination results.

Upon this phenomenon is based the division ot

humans into tour main blood groups and into a tew aubgroupa.

This agglutination is a speoitic reaction and

depends upon two substances, one in the red blood oells,
called agglutinogen; and one in the serum, called
agglutinin.

This reaction is or the same order as the

Widal and other specific agglutination reactions (ltH).
Landsteiner (151) has described two agglutinogena
A and B; and two agglutinins Alpha (or anti-A) dnd Beta
(or anti-B).

Several nomenclatures of the Landsteiner

blood groups showing the respective agglutinogen and
agglutinin are given in table I.

The International

Nomenclature was otticiall7 recognized
Community or the League of Nations.
numberings are aonfusing.

by

the

Health

The Moss and Jansky

The International Nomen-

clature corresponds to the agglu. tinogen content in the
red blood cells.

It is possible for an individual's

TABLE I

( 151)

Classification & oo.m.position ot
blood groups:
Inter• Jansky • Moss
•
national •
• Ni.llllber- • Number- •
• ing
• ing
•
NomenQla ture
•
0
A

•
I
• II
• III
• . IV

a

AB

•

IV

• II
. III
• .. I

•

•

the Ladsteiner
Cells

• Serum

.Aggluti-. Agglutinin
nogen
•
•

• Alpha
A
B
A&B

&.

Beta

Beta

•

Alpha

•

serum to lose or ohange its speoifio iso•agglutin1na
but cell receptors or iso-agglutinogens are constant,
and sinoe the blood groups are named by the type ot
iao-agglutinogen present in the oells, the blood groups
do not ohange.
lite.

They are inherited and last through

The blood group speoitioity if not present at

birth, whioh it usually is, appears within three months
(54, 115).

During embryonic development and the first

three months of life, the human being does not possess
speoif'io aggl·11tination power in the blood (40).

The

results of the sera of eaoh group mixed with the red
blood oells of eaoh other group is shown in Table I I
and as can be seen, from the table, the blood group of
any individual may be determined by testing his red
blood cells with the sera of A and B grou.ps.

Group O

red blood oells will not agglutinate with either serum.
The cells of group A B agglutinate with eaoh serum.

Groi.lp A oells will aggli.ltinate with B serum and group
B oells will agglutinate with A serum.
TABLE

Serum ot
Group
0

4

~

II
~

• Aggluti-

II

•

Red Blood oells ot
group
A
0
•
• B • AB
•

.• Aggluti-.•

nin in
• no gen
• in oella • serum
• Alpha &
•
• Beta
•
A
• Beta
•
B

(151}

•

Alpha

•

•

•

•
•

•
•
•

•

•

II • # •
=II •
• II •
•
• ... •·
•

A.B
• A&B
•
signifies agglutination
signifies absenoe ot agglutination

~

i-

Should there be any oase of doubt following the
reaction of unknown oells with known serum, the unknown
serum may be tested with a known oell group suspension.
Only those agglutinins are present in the serum tor
which there are no
Aa:

aggl~tinogens

in the red blood cells.

Red oells of group A have agglutinogen A in them,

their serum has anti-B or Beta agglutinin in it; red
oells of group B have agglutinogen B in them, their
serum anti-A or Alpha agglutinin in it; red cells ot
i

group A B have in them agglutinogen A and B, their serum
has no agglutinin in it; red oells of group O have no
aggliltinogen in them, their serum has both Alpha and
Beta or anti-A and Anti-B agglutinins in it.

Because

group A B has no agglutinin in its serum and cannot
agglutinate any red blood cells, it has been called the
universal recipient.

Group

o because there are no

agglutinogens in its red blood cells and they cannot
be agglutinated by any serum has been called the universal donor (54, 56, 151).

Some men advise using

universal donors tor transfusions always and of giving
any tYPe ot blood to universal recipients (113, 114)
but this is dangerous without satisfactory erossmatohing, for it otten eauses reactions (54, 106, 108).
It should only be used when it is impossible to get the
proper type of blood
The Teehnio of Blood Grouping:
In. blood grouping we must oonsider the sera, the
red blood oell suspension, and the various grouping
tests.

Only sera ot A and B groups are neoessary as

already explained.

Sera of high titer should be used

to prevent errors, as blood oells very in their sens1-·
tivity.

Serum trom certain pathological conditioned

patients may show pseudoagglutination and autoagglutination whiah may

~e

mistaken for isoagglutination.

The: sera ot very young and very old individuals usually
shows low agglutinin titer - therefore, sera or healthy
middle aged individuals should be used for testing sera.
The blood is collected in small test-tubes, allowed to
olot, the olot is rimmed with a stirring rod, and the
serum is separated by aentrifuging or standing in the
1oe box over night.

The serum is transferred by pipettes

to small sterile vials oapaoity ot about two oo eaoh.

Sterile teohnio is used throughoilt the entire prooedure.

The serum is stored in an ioe box; preserva-

tives are unneoessary, but phenol one part of five
per oent in normal saline to nine parts of serum has
been used (151).

Different oolored preservatives·

(118) have been reoommended and used to differentiate
the sera

by

oolor.

To A serum per co is added 0.01 ao

eaoh or one per oent aqueous solution or neutral
aoritlavine and 0.5 per oent aqueous solution of basio
fuohsin.

To B serum per oo is added 0.01 oo ot per

oent aqueous solution or brilliant green.

Commeroial

sera has been round not always reliable (120).
The red blood oell suspension should be fresh.
Blood maybe gotten by stilet punotilre or the lobe or
the ear or end of a finger as for a blood oount.

Two

drops or the blood are suspended in 5 oo ot normal
saline (151) or in 5 oo of one per oent sodium oitrate
in normal saline solution ( 54).

The s'-lspension sh91.1ld

be washed if there is the tendenoy or pseudoagglutination or rouleaux formation (54 & 56).

This is done

by oentrituging, pouring otf the supernatant fluid
and resuspending in normal saline making a two to five
per oent suspension.

It the serum is to be tested

also, venepunotllre is preferable, using a tew drops
for the red oell suspension and the serum prepared aa
already desoribed.

Kno~n

oell suspension may be pre-

served (see blood preservation) then washed and
resuspended when needed for testing unknown sera (151).
The blood grouping tests may be done macrosopically or microscopically.

LandstP.iner's macroscopic

or microscopic technic (151):

A drop of ea.ch of the

unknown cell suspension, of saline, and. of testing
serum are mixed in a small test tube, inside diameter
7 mm.

Upon standing, the reaction can be seen with

the naked eye after a few minutes but should stand
an hour.

If desired a drop of the mixture may be

transferred to a slide with a stirring rod and looked
at with a microscope low power.
run with this procedure.

A control should be

The reaction can be

facilitated by centrifuging at 2000 revalutions per
minute for three minutes.

The tubes are then shaken

until the control is evenly suspended and then read
with the naked eye.

The usual method used (151):

One drop of A serum isput on the left end of a slide
and one drop of B serum put on the right end of the
slide, and one drop of the unknown cell suspension
is mixed with each.

The slide is tilted back and

forth for 5 to 10 minutes, then the drops are
covered with cover clips to facilitate microscopic
examination.

Examination is completed after an hour.

Pseudo agglutination is possible in this last test (151).

Young ( 155) states that typing a.nd cross matching
by covering the

~erum

and red blood cell suspensions

with a cover glass is very dangerous, for that
vents agglutination or hemolysis.

pre~

And he cites

cases in his own experience to prove this.

The

hanging drop method. observed for 45 minutes to an
hour makes the procedure safe when done at 37 degrees
centigrade or room temperature (54, 56, 155).

SOURCES OF ERROR IN PI,OOD GR01TFING

False negative reactions:
Weak sera or sera of low titer and old sera
may not have any affect upon the red blood suspensions.

Therefore, it is well to use controls.

If

the mixture of cell suspension and serum are not
observed for a long enough period of time a positive
reaction may be missed.

Very concentrated red blood

cells delny snd weaken the reaction.

This may be

avoid.ed by making a two to five per cent suspension
of the red blood celJs.

The agglutinogen in some

red blood cells is very insensitive and may be the
source of error.

Such a patient of A B group was

transfused 18 times with B blood before the error
w.as detected.

Hemolysis some times appears with

fresh serum and masks agglutination, for the blood
cells are hemolyzed as fast as• they are agglutinated;
but the scarcity of cells in the suspension should
indicate hemolysis.

The solution will also have a

tendency to take on a pin}; color, but this is hard
to detect in poor or artificial light.

Hernolysis

has the same significance as agglutination and never
takes place without agglutination.
been kept in the ice

~ox

Serum that has

over night will not show

this sudden hemolysis action (106, 108, 151).

False positive reactions:
Pseudoagglutination is the rapid settling
out of red

~lood

cells in acute infections.

The

cells settle out in piles like coins known as
roule~ux-formation.

When the rouleaux are very

marked, the cJumps become more irregular and
simulate true agglutination; but the rouleaux are
always present and result from the action of the
acutely infected person's serum upon its own cells
as well as the action of that same serum upon any
red blood cell suspension.

This phenomenon is used

in clinical medicine in the sedimentation rate tests
(32).

Other factors whlch favor its occurrence are

high concentration of serum and high temperature.
It very rarely occurs in Landsteiners test-tube test.
On the slide, it can be distinguished from isoagglutination by a drop of saline or ,,.,y pressing down
on the cover slip over the preparation, either of
which breaks up the clumps in false agglutination
but will not affect true agglutination (29, 54, 106,
108, 151, 158).
Autoagg1utination:
Cold or

autoaggluti~~tion

takes place with many

sera mixed with red blood cells at low temperatures,
as zero to five degrees centigrade.
or non-specific (81).

They are specific

In some pathological conditions

autoagglutination takes place even at room temperature.

This can be overcome by making a two to five

per cent suspension of the cells in normal saline.
Among the conditions causing it are:

Paroxysmal

hemoglobinuria, syphilis, sybilitic or hypertrohic
cirrhosis of the liver, hemolytic icterns, pneumonia,
Raymonds disea.se, tryanosamiasj_s, and severe
and cachexia.

an~mias

Autoagglutination is in some cases

inherited (29, 30, 54, 106, 108, 140, 151).
Panagglutination:
Some saline red blood cells suspensions after
having been kept a long time will be agglutinated by
any serum, even their own, and by the serum of A B
which has no agglutinins in it.

Friedenreich says

this is due to bacterial contamination (15, 29).
Panagglutination may also occur in bacteremia and in
chronic suppurations (29).
Anomalous agglutinins:
Anomalous agglutinins were found in about three
per cent of sera according to Lansteiner and Levine

(P2).

These rarely a.ct at room temperature

and the

red blood cells o:f such sera show normal grouping
reactions.

These may be specific cold agglutinins

(106, 108, 151).

Various tissue extracts cause f'alse agglutinins
as Wharton's jelly fr.om the umbilical cord (106).

REACTIONS FOLLOWING TRANSFUSION
Reactions following blood transtusion vary
with the different olinios and the difterent operators all the way trom one halt ot one per oent to
twenty per oent, if reports oan be depended upon
(84, 86, 104).

Aooording to Lewisohn {84, 86}

the reactions in pne hospital when done by him were
only one halt ot one per oent,

b~t

when left to

the hospital start ranged trom 10 to 20 per oent.
The operator

and his teohnio must be an important

tao tor.
Incompatibility reactions:
Inoompatibility between the donors and the
recipients blood may be due to the one of the following causes:
d~e

{a} Errors in

gro~ping

whioh is itself

to the following in order ot greatest frequency:

Poor teohnio tor •htch there is no justitioation;
the use of low titer or contaminated test sera; weak
agglutinins or agglutinogens in the reoipients blood;
pseudoagglutination, cold agglutination and the subgroups; contamination ot reoipients blood by bacteria,
anomalous or atypioal agglutination (29, 106, 108).
(See ohapter on errors of blood grouping) (b)

In-

discriminate use of the universal is dangerous because
incompatibilities do ooour from the use of such (41,

{o)

106, 108).

Immune 1soanti-bodies and hemoly-

sins may oause incompatibility (106, 108}.

For a

discussion ot symptoms, treatment and results ot
incompatibility see the chapter on transfusion
nephretidea.

(d)

Incompatibility of white oella

have been found by experimentation.

Suoh inoom-

pa ti bili ty tho11gh not common do give reactions.
( 84 ' 86 ' 104) •

Citrate Reaction:
Mild reactions whioh oocur so commonly follow•
ing transfusion with some operators and so rarely
with other operators have been blamed on the toxicity

ot the sodium citrate solution used by the advocated
of unmodified blood:, and upon the incipient coag11lative changes in the transf11sed blood by the citrate
advocates.

But Lewisohn (84, 86) blames them to

improperly prepared citrate, to unclean apparatus,
and to poor teohnio.

His citrate solution must be

prepared with triple distilled water and made up with
normal sodium chloride.

Refer to separate discussion.

These reactions are oharaoterized by mild rigors with
transitory rise in temperature following a mild ohill,
and are as often present when citrate is not used
(16, 67).

Some olaim that citrate reactions are not

harmful but benefioial.

It would be better to use

other methods or chill and fever, whioh can be oon-

trolled and controlled independantly of the
transfusion (10, 138).
Allergio Phemomena:
rf there is a history of allergy in the
recipient, a tast donor should be used and if a
reaotion still ooours it ean be relieved with adrenaline and morphine (163, lOla).
should not be used (29, 112).

Allerg1o donors
It the reo1pient has

had former transfusion or serum administration,
there is danger of an anaphylaotio reaotion.

The

greatest danger of this is between three to six
weeks after the administration of blood or serum.
Therefore, upon repeated transfusion even from the
same donor, the blood of the recipient and donor
should be oross-matohed (16, 29, 106, 108}.

The

allergic symptoms may take the torm of urtioaria,
asthma, localized edema, or severe shook.

Edema

and urt1oaria are dangerous if they hit the glot1s.
It suoh ooours, intubation or traoheotomy may be-

oome neoessary.

Epinephrine is used in the allergio

reactions. (16, l-25f

One death from anaphylaxis

has been reported {25).
Systemics or constitutional reaotions:
Reactions seen after the transfusion of certain
pathological conditions in which there is a very
active hemolytia agent at work.

The latter may appear

in purpura,

hemolyti~

jaundioe, leuoemia and sepsis.

Reaotions or this type can neither be foreseen nor
a.voided, but the possibility of their ocourr'ance
should be kept in mind so that prompt measures may be
instituted to counteract them if they should oocur

(16, 84, 104, 116)
Heart failure and pulmonary edema may result
trom the transfusion, depending, of course. upon
the condition ot the patients oiroulatory apparatus.
It is made more possible in a patient with a weakened
heart oondition due to a long standing anemia, previous failing heart to whatever oause, valvular
disease, and arterial sclerosis and hypertension
(12, 105).

Rapid administration inoreases the danger

or aoute cardiac dili ta ti on, especially when the
myooardiwn is all ready weakened.

a.rile pointed out

that the hearts work increases in geometric ration
to the volume of' blood. (147)
by giving the blood slowly.

It oan be prevented
If' it ooours venesection

must be performed at onoe (12).

The

amo~nt

of blood

administered sho..ild not exceed· 1/6 to 1/5 of the
oaloulated circulating blood of the recipient because
of the danger of overloading the circulatory system

(29).
"Multiple emboli appear occasionally, usually

r

in patients with endocarditis, or a blood stream

infeotion" (105).
ind~oed

A thrombooyte orisis oan be

in oases of thrombooytopenia purpura by

blood transfusion {142). nRetinal hemorrhage probably

oco~s

more frequently than is thought" (105).

Transtusional fatalities are more frequent in diseases
of' the blood and during sepsis than in acute hemorrhage (29).
Transmission ot disease:
The transmission ot disease from the donor to the
recipient is a real danger and must always be g·11arded
against.

The reoipient may also be endangered by blood

from a person whose hemopoetic apparatus is not functioning properly (29). (Refer to separate disoussion)
Embolism and thrombosis:
The danger or embolism and thrombosis is small,
especially if' faultless technio is used (29); except
in endooarditia and blood stream inf'eotions (125}.
Air embolism, the greatest f'ear of distorioal transfusion and accepted oause of' many deaths is of no
danger

with proper teohnio, "The amount of air whioh

may be aooidentally injeoted into

h~ans

during an

ordinary intravenous injeotion should oocasion no
olinioal manif'estatioIB" (146}.
The

~se

of olean apparatus:

Any debre in the transtusion apparatus, whether
trom former transfusion or tubing, even though minute

causing reaotions, some times alarming reaotions
(84, 86, 106, 108).

Therefore, transfusing appara-

tus must be metioulously olean.
clean right after using.

It is easier to

It is washed with running

water several times after the water running through
it is olear.

After it is clean it is dried with

compressed air, wrapped in towels and sterilized
thoroughly.

It there should be may partioles ot

blood remaining in it, they will probably cause a
reaotion in the next recipient.

New r1.1.bber tubing

causes serious reaotions from the sultur oompounds
and powder washed from the tubing.

The tubing is

soaked tor several hours and then boiled in five
per cent sodium. hydroxide solution for ten minutes.
It is then treated in the same manner in a two per
oent hydroohlorio acid solution and washed over
night in running water and sterilized tor 30 minutes
at 20 poands pressure in the autoclave (log, 111}.
Lewisohn's teohnic (85) is much more

thorough~_·it

follows:
The apparatus is thoroughly washed with cold
water after each transfusion, then with dilute solution ot green soap to whioh has been added oo.mpound
solution of oresol to make about

l;~

then thoroughly rinsed in tap water.

solution, and
All parts are

then put in a large pan containing sodium hyderoxide

in 0.1% solution and boiled five minutes and then
rinsed in distilled water to remove the hyderoxide,
rewashed with triple distilled water for the glass
ware and the rubber tubing, then assembled and
sterilized in metal boxes or speoial bundles in the
autoolave.
The glassware and rubber tubing are boiled
separately.

The needles are sharpened before being

treated and are_boiled for 3 minutes in 0.1% solution

ot sodium hydroxide.

The reoipient and donor bundles

are done up and labelled separately for autoolaving,
oontaining:

Donor:

Two pyrex oylinders 500 and 10 oo,

respeotively, one glass rod, two towrniquets, two
needles gauge 13 and 15, Leur adopter and rubber tubing, one ampule or 30% so_ditun oi trate.

Reoiptent:

A metal box containing glassware, rubber tubing and
oannulaa (85).
Coagulative and temperature ohanges in the blood:
It has been demonstrated that blood is toxic
in direot proportion to the ohemioal alterations
toward ooagulation.

This is particularly dangerous

because the change invisible undetectable in the
preolot state (54, 106, 108).
Warmed blood that is heated above body temperature
whether given while above body temperature or not,
hemolyzes due to the efteot of the heat upon the

erythrooytes.

The symptoms, treatment and e:f'teot

are the same as :f'or imoompatibility (12, 105).
Blood may be chilled or even kept in the ioe
box without deleterious e:f:f'eots if' it is warmed to
body temperature when given.

But if' it is given

oold, it is said to oause a reaotion.

This may

account for some of' the reactions that have been
blamed on to oitrate (10).

However, Lewisohn (85, 86)

maintains that injeoted cold blood does not give any
reaotion.

But it does sound reasonable that oold

blood might give a chill.
Death :f'rom blood transfusion:
Death :from blood transfusion is mainly due to
elimination o:f :foreign substanoes overtaxing certain
organs as the kidneys, liver and heart oausing insu:f':f'ioienoy of' those organs, as in the pest renal
nephritides :f'rom incompatibility.

Fatalities are

more :frequent in t:raas:fusion in diseases or the blood
and in sepsis than in aoute hemorrhage (29).

The

death rate :f'rom. blood transfusion was figured by
Tiber (141) in 1930 to be 0.39 per 1000.

A muoh

greater ratio than this of' transfused persons die, but
it is figured that they die of the disease :for whioh
they were transfused.

IOST TRAIYSFTTSION NEIRRITIDES

The post transfusion nephritides are, due
to their clinical aspect, physiopathological
characteristics, modes of appearance, related to
the acute chemical nephritides.

The treatment is

not satisfactory but prophylaxis is.

The prophy-

laxis is ensuring compatibility of blood before
the transfusion; not warming the nood above body
temperature; and stopping the transfusion with the
first signs of distress.

The prognosis is guarded

to favorable with exceptions (16, 116, 143).
The

~our

clinical phases:

Clinically, there are four phases of the transfusion nephritis:
First:

The alarm period with precocious sub-

jective symptoms, and the transfusion is discontinued with a minimum of 20 to 30 cc of blood having
been· injected.
plication.

Therefore, there may oe normal

The symptoms are:

com~

tingling pains

shooting over the body, a fullness in the head to a
headache, cardiac consciousness with a feeling of
tightness and constriction over the precardiurn and
chest; an excruciating throbbing pain in the lumbar
region; slowly the face becomes prematurely colored

a dark red to a cyanotic line; respiration becomes somewhat labored and the pulse rate slow,
dropping suddenly to 20 or 30 beats a minute;
vomiting, more or less violent rigor; unconsciousness may be P!P-sent for a few minutes; urticarial erruptions arpear in ahout half the cases;
sudden palor followed

~y

cyanosis; the pulse be-

comes very rapid, weak and thready; the skin
cornes cold and clammy; in

fifter~

a chill occurs followed by a

hi~h

~e

minutes to an hour
fever,

te~perature

ranging from 102 to 106 degrees; the patient may
become delirious (5, 16, 104, 121, 143, 147).
~atient

.A.

The

may rarely die immediately (113, 115, 147) •
reaction described. by DeGowin is interesting,

"When 125 cc of "blood. had been given, the :patient

complained of a feelircg of constriction in the chest
and severe shortness of breath.

The administration

of bJ.ood was promptly discontinued.
tensely cyonotic and dyspneic.

She became in-

A marked chill occurred

and the oral temperature rapidly rose to 106.2 degrees
F.

The pulse rate was 140 and the respiration rq,te

44 1er minute."

The next day tbe patient was feeling

netter.
Tbe delayed reaction:
However, these symptoms may not arrear until 200

to 300 oo or blood have been given, or they may not
appear until the transtusion has been oompleted and
thus be oompletely skipped.

The following pre-

oautions should always be taken to proteot the patient
against

re~otions

and to show the dootor the reaction

before too mu.oh blood has been administered if there
is going to be a reaction.

1.

No morphine should

be given before the blood transfusion, for this would
mash the cardiao consciousness, lumbar pain and head
ache.

2.

Every precaution for proved compatibility

should be taken.

3.

'l'he

above body temperat..ire.
be begun slowly.

5.

~lood

4.

should not be heated

The transfusion should

Every sign of discomfort on the

part of the patient should be minded and watched.
However, there may be seemingly reactions that are
psyohio, or oomatose and sleeping patients may not
show reaction (16, 143}.
Second:

Anuria and ol1gur1a start about and

between six to twenty-tour hours after the transfusion
with or without a phase of alarm.

The condition and

the taking of a urine speoiment is suggested by hematuria or because no ·llrine has been passed.

The bladder

is found to be praotioally empty, albumen, erythrocytes with various amounts ot alteration, diminished
urea and ohlorides, and granular oast in the sediment

are found.

An interval or improvement may appear,

lasting tor two to six days with or without jaundioe
and always with oontinued oliguria or anuria.

Then

any variety or evolution may be observed: oomplete
anuria to the end reaohing a ureaio-like oondition
and death in 8 to 12 days; or en the third to tourth
day poor ooncentration or i.lrine followed by oliguria
oranuria; or a permanently poor oonoentration diuresis;
or else a better oonoentration with less water eliminated.

The general condition with regard to the under-

lying disease tor whioh the blood trans:rusion was given
is usually undisturbed in its oourse.
pulse andtension usually unohanged.

Pains are absent,
Conseoutive blood

examination shows a steady increase in ozotamia and
non protein introgen and a decrease in alkali reserve
and oarbon dioxide oombining power with slight variation in the chlorides.
may not be inoreased.
reduced.

The blood pressure may or
The kidney funotion tests are

Edema is always present.

The oondition

resembles experimental uranium. nitrate poisoning
or biohloride or meroury poisoning.

The entire phase

lasts about ten days (16, 143).
Third:

The hydrio orisis phase is often

skipped~

In this phase large amounts or water are eliminated,
1800 oc within 24 hours.

The urine is poor in urea

and chlorides, ozotemia, increased non protein intro-

gen, decreased alkali reserve and oarbondioxide of
the blood are found.
redu.oed.

The kidney function tests are

There is always edema.

The amount ot urea

in the urine and the amount of urine excreted are
.better prognostic stgns than the amount of hemoglobin
excreted.

The toxemia lags behind the elimination.

Fourth:

The last or terminal period is 8 to 12

days or even 15 to 25 days after the transfusion was
given.

.rhere may be two possibilities, either favor-

1

able or unfavorable with all the range between.

The

favorable oases after a few days of crisis have normal
diuresis with ohloruria and ozoturia and the
begins oonvalesoenoe.
been observed.

p~tient

Permanent sequelae have never

In the unfavorable oases power ot kidney

concentration rem.ains very low and death results in coma
with uremia manifestations. (16, 143).
The symptoms of unfavorable oases:
The unfavorable oases result from inoompatible
transfusion, and there is always the precocious aggravation.

Dige.stive disturbances are always present,

beginning with a loss of appetite and then vomiting
and diarrhea appear and eventually urea and ohlorides
appear in both the vomitus and stools.

There are

pulmonary symptoms of Oheyne-Stokes syndrome, whiah
may be related to

the

acidotio condition; nervou•

symptoms

or

a progressive torpor from fatigue to

somnolenoe and ooma interrupted by spasmodie movements or oonvulsions.

Death ll.su.ally resu.lts two

to three days after ooma appears.

The enttre

time

of the nephritis is usually about ten days and very
rarely 25 days (16, 143).
Other assooiated olinioal symptoms:
Other assooiated clinical symptoms of post
transfusion nephritides are: eruptions, peteohial
or urticarial, jaundioe, edema, mild hematllrias with
albumenuria, oylindric granules, increase of

n~ea

and

slight deorease of alkali reserve, and with erythema,
urtioaria, fungaoious edema and artioular pains.

There

are the benign or reflex nephritides, some lumbar pain,
anllria of a varying d...iration, then diuresis and disappearance of the disturbanoe without sequelae (143).
Strange, but there seems to be no simple relationship between the amount of blood injected and the
severity ot the reaction nephritis {143).
Explanation of Post transfusion nephritides:
The explanation of post transfusion nephritides
is that the blood is hemolyzed in vivo from inoompatibili ty; or from heating the blood too muoh, slightly
above body temperature; or .from blood peouliarities;
or the oondition may be due to metabolio disturbances.

The hemoglobin from the destroyed red blood oells
is exoreted by the kidneys with one ot the following
possibilities ooourring:

(a)

It the reaotion ot

the urine is above pH 6.0 the hemoglobin will be
exoreted

as oxyhemoglobin with no ill effects re-

sulting.

(b}

But it the reaction ot the urine is

below pH 6.0 and there be s·iltf'ioient oonoentration
of Na Cl (about 1%), brown pigment will be precipitated in the kidney tubules (5).
It is reasoned that the hemoglobin passes through
Bowman's capsule in the dil·\.lte transudate at about
the pH ot the blood.

In the tubules reabsorption

concentrates and increases the aoidity ot the urine.
The hemoglobin is precipitated, probably aa hematin.
The tubules are ocoluded and renal tunotion is impaired (5).
The mechanism or explanation by which incompatible blood damages the kidneys has four possibilities aooording to Bordley (16).

1.

The meohanioal

blookage ot the tubules renders the kidney :f'unotionless as an excretory organ.

2.

There are or may be

certain bodies in the injected blood to which the
kidneys are sensitive, and tunotional decline results
trom a looal reaotion of the nature.or anaphylaotio
shook.

3.

"The immediate

trans:f'~sion

reaotion

brings about a metabolic disturbanoe that atteota
the renal tunotion.

4.

By the action or toxio

substances set tree in the blood at the time ot
transfusion, the functioning renal tissue is so
severely damaged that it is unable to perform its
tunotions" (16}.
Renal pathology and autopsy findings:
-The renal pathology seems to be the obstruction
of the tubular lwaens with masses of pigment derived
from the hemoglobin (4la, 105).

The autopsy findings

ot the kidneys are: "edema and cellular infiltration
of the interstitial tissue, dilatation

or

the inter-

oapular spaces of the glomeruli, dilitation ot the
convoluted tubules, advanoed necrotic changes in the
tubular epitheliwn, espeoially of the collecting
tubules; with deposits or pigmented droplets in many
of the cells and finally, the

appearance in the

tubular hemina of leuoocytes, large phagocytio wandering cells, desquam.ated epithelium and peculiar
pigments globules or various sizes" (16).

This pig-

ment· is s1.1ggesti ve ot hemoglobin, and exoept tor it
the kidneys are much like the kidneys following death
trom merourio chloride poisoning.
necrosis of the liver.
vary (16, 4la, 105).

There is central

Findings in the other organs

Experimentation and treatment:
Experimentation study on dogs tollowing the
intravenous injection or dog hemoglobin showed that
if the urine was alkaline, the injection was without
harmful effects; bat when the urine was acid, renal
insuffioiency resulted, there was inoreased urea
nitrogen (120 to 362.6 mg percent) and oreatinine
(4.5 to 15 mg percent), coma and death in 4 to 10

days resulted.

The experiementation indicates the

line of treatment in
d~e

hemoglobinur~a

to transfusions, paroxysmal

blaokwater fever.

whether it be

hemoglobin~ria,

or

Any type of therapy tending to

•

reduce the preoipetative taotors - that is acidity
and sodinnohloride oonoentnation value.

sho~ld

prove of

The alkaline diuretics are transfusion ot

.aocli\.Ull, bioarbona te as soon as possible should tend
to minimize the precipitation in the tubules (5, 4la.).
The

treatment is prophylaxis by proper blood

grouping bef'ore the transtusion is given ensuring
compatibility; not over working the blood; and close
observation or the patient during the injection,
especially early; the injection being given

sl~w;

and

discontinuing it if there are any signs of reaction.
The treatment consists of adrenaline 5 to 10 minums
(0.3 to 0.6 oo}, atropine 1/600 to 1/150 grains,

with morphine 1/8 to 1/4 grains (121, 125) and
intravenous solution

or

sodium bicarbonate

10.7:1000 given right away. A oompatible blood
transfusion is very helptul (143).

If vomiting

and diarrhea are present injections or normal
saline with gluoose should be used.

The rest ot

the treatment is as in any acute nephritis (104,
121, 125, 143}.

In extreme oases radical experi-

mental procedures have been tried as kidney deoapsulation or de-inervation by the injeotion of the
proper dorsal nerve roots or by high spinal anesthesia.
Immediate transfusion ot compatible blood has been
reoommended (143).

THE USE OF CITRATE BLOOD

In the oontroversy of the whole or the unmodified method or blood transfusion versus the
citrated or the modified method or blood transf..ision oonsideration has been given:

The oi tra te

itself; the efteot ot oaloium immobilization; disturbanoes in the hydrogen in oonoentration of the
blood; injury of platelets; ohanges in fragility
of the red blood oells; alterations in the hemostatio powers of the blood; immobilization of the
white oells; ohanges in the opsonio index; the
development of the antioomplimentary properties of
the ser11m; alterations in the immunologio reaotions

ot the serum in respect to antitoxio, virnoidal,
baoterioidal, and other antibody properties (43, 58,
~5,

144, 145).

The oitrate reaotion:
Citrate itself oan hardly seem a oause for post
transfusion reaotions.

But "oitrate reactions" has

been mentioned by many writers as being oaused by the
oitrate {17, 79).

It is "oharaoterized by an unex-

plained slightly delayed febrile response; it is a
common enough reaotion even when the blood is given
witho~t

the oitrate, and it fortunately seems harm-

less."

(16 & 67}

Lewisohn (85, 86) thinks that

the reactions with citrated and unoitrated blood
are about equal in :rrequency o:r occurrence.

He

blames the mild post transtusion reactions upon unclean and contaminated apparatus (84).

Sodium oitrate

is rapidly oxidized and disappears quiokly trom the
circulation when given intravenously (54, 122).
Hemorrhage does not
sodium citrate.

etteot this disappearance ot the

Repeated doses disappear more alowly.

Citrate given orally causes alkaline urine but there
is only a small amount ot the citrate in the urine.
Intravenously 70 milligrams per kilogram of body
weight, ma.king over about tive grams in the average
adult, have given SJDlptoms.

The f'atal dose is between

0.4 and 1.6 grams per kilogram of body weight, making
the :ratal dose abou.t 70 grams in the adult.

The toxi-

oi ty ot it depends upon the rapidity ot injection,
the taster it is injected the more toxic it becomes
(122).

In the average transiusion ot 500 coot blood,

1.25 grams ot sodium citrate would be given.

This is

one-tourth the maximum sate dose (54, lOla).
Calcium immobilization:
"Some experimental work on citrate toxicity suggest that when the calcium content of the blood has
been depleted as it otten is in patients needing blood
!!fl""'...

transtllsion, a smaller doee than five grams may be
toxic.

Possibly therein lies the reason that the·

citrate method gives more reactions than noted with
the whole blood method." (lOla)
are thought or

~ound

It the recipients

to be low in blood calcium, they

oan be given oaloiwn gluconate intravenously, and the
condition taken care ot.
Sodium oitrate effects have been studied both
in experimental animals and in the various blood tests,
and its injurious etfeots upon the platelets, red
blood oells, opsonio index, antioomplimentary properties of serum and lowered phaoooytio properties
refuted (og, 122).
•

There is no increase in the

fragility of the white or red oells (84, 95).

B·11t

there may be some ef'feot upon pH and oalloidal equilibriill11 whioh is theoreticalas yet (95).

The hemostatic

power or citrated blood as compared to uncitrated blood
in p11rp11ra hemorrhagica, hemophilia, and hemorrhagic
disease of the new born oannot be definitely stated;
but intravenous citrate solutions have been said to
shorten the clotting time in hemorrhage exoept when
due to platelet disturbanoe (99, 117).

But according

to Lewisohn (85, 86) and Jenings (73) citrate blood
has been proved to be harmless and may be used in any
disease where transfusion is indioated•

Ef'teots ot oi trate upon immunotranst·usion:
In the preparation ot oonvalsoent sera the
preservatives used do not atteot the potenoy ot
the immune bodies (eg ammonium. sulfate, trioresol}.
And as tar as

o~r

present knowledge, oitrate would

have no d·e11 teJ;"ious efteot upon immune bloods (92,
102• 159, 160).

However, Colebrook and Storer (32}

showed that "the addition of deoaloitying agents
to normal blood considerably reduces its power to
kill staphylooooous and streptooooous in some way
intertering with the tunotion of the leuooaytes.
But citrate did not affect the pneumoooooidal power
ot blood (2?).

However, it was found that the

oomplement content or unoitrated blood was increased
over that of oitrated blood and hence the baotorioidal power of the blood which is very olosely related (109, 111).

Okomoto (101) oonoludes that un-

oitrated blood has no advantages over citrated blood
in transfusion ot rabbits upon normal and immune
agglutinins and normal and immune hemolysis.
Comparison of citrate blood with unoitrated blood:
It would seem that with a very sick patient
"skill on the part or the operator and minimal disturbanoe to the patient are matters or tar greater
importance than the supposed merits ot anyone method
over those or another." (111)

The citrate

method~

minimizes the disturbanoe to the patient; veins
need not be exposed; the blood may be given slowly;
the skill is easily developed; and the equipment
is simple, easy to handle and olean, and the donor
is not directly exposed to the reoipient.

In

inteotious diseases and blood dysooasias, the advantage may be with unoitrated blood, it would seem;
but the evidence is inoomplete (109, 111).
In any transf'usion the delicate blood tissue 1•
traumatized, perhaps as muoh in the rush method as in
the anticoagulant method (109, 111).
Advantages of' the citrate method:
The advantages of the citrate method are:

First,

its simplicity; seoond, speed is not necessary and
so the blood oan be given slowly enough to anticipate
severe reaction and to minimize speed shook.

It is

true that slight febrile reaotions {l to 2 degrees F)
ooour more frequently following injeotion of citrated
blood than ot unoitrated blood, but these are ot no
serious moment.

Third, the coagulation time is not

prolonged as has been thought, but it is actually
shortened.

Therefore, there are no diseases in whioh

the use ot citrated blood is oontra.tndioated.
The citrate method would seem the method

o~

choice tor the average practitioner who has only an
oooasional transfusion to perform.

For the expert

who does many transfusions, one of the direct
methods may be desirable (54).
Dangers of unmodified blood:
The dangers ot unmodified blood are:

First,

the possibility of a olo• forming in the apparatus
and interrupting the procedure.

this is avoided

by the utmost speed and preoision.

Seoond, one

cannot then inject a small amount ot blood slowly
to see whether a severe reaction is imminent.

Third,

the donor must be at the bedside of the reoipient,
this is objectionable to nervous or oritioally ill
patients.

Fourth, blood is increasingly toxio as

the ohemioal ohanges preceding ooag11lation take
place; so it the blood in the apparatus is on the
verge of clotting, one is actually administering a
toxic substance (54).

ACCIDENTAL TRANSMISSION OF DISEASES
BY BLOOD TRANSFUSION
There have undoubtedly been many more diseases
aooidently transmitted than have been reported.

In

a survey made by Hendrick (29) in 1935, he reported,
"thirty-five oases of syphilis, thirty of malaria,
three of measles, two of smallpox, one or typhus
fever, three of' allergy, and three of tuberoulosis."
transmitted by transfusion.

There was a death two

weeks :f'ollowing an aooidental transfusion from a donor
with aoate myeloid leukemia (29).
Byphilis transmission:
The first aooidental transmission of syphilis
oy transfusion was reported in 1915 (112a).

There

has been a total of 68 oases reported. (112a).

One

oase in whioh two generations were given it direotly
by transfusion or an expectant mother.

Both the

mother and the unborn baby got syphilis.
The way suoh mistakes oan be eliminated is for
the physioian to never do a blood transfusion without
the written report of the laboratory regarding the
prospective donor's serology.
not be taken.
hours.

A verbal report

sho~ld

A Kahn test oan be performed in two

If the emergenoy cannot wait that long and

there are no available tested and serologioal donors
obtainable, the folks of the expected

re~ipient

after

having the situation explained may be asked to sign
a written release, releasing the dootor if the patient
should get syphilis following suoh an emergency blood
transfusion.

S\lch a transmitted syphilis has no

oanohre, but in about two and one halt months the
seoondary rash may appear as in any oase of syphilis
and the other clinical symptoms usually resemble
those of syphilis gotten in the usual manner (75).
Any one who has ever had syphilis should not be
a donor tor blood transtusion, although many physioians
think there is no danger ot using inactive oases for
donors, except when it is a life saving procedure,
and then having the patient or other responsible person
sign a permit releasing the dootor in case the patient
gets syphilis.

The dootor may in the absence of a

responsible person and with a patient that cannot give
a rational consent, take this responsibility upon
himself and be within his legal right of' exercising
a "reasonable care".

It may be the means of saving

the patients life in an exoeptional case (?5, 7g).
Malaria transmission:
Malaria has been transmitted aocidently by transfusion to both donor and reeipient.

ot oourse, trans-

mission to reo1p1ent is more common, and has been done
even when the donor did not know he had malaria, or

when he had not had an attack for forty years (24).
There have been reported f ou.r oases ot malaria from
one donor within two months and a.bou.t thirty oases
in all (29).

The incubation period varies trom one

to titty-six days with an average from one and one
half to three weeks.

Less than halt ot the donors

had demonstrable malarial parasites in their blood
smears, and less than half of them ever had symptoms
of malaria.

Protection can only be had by exoluding

all inhabitant of malarial regions from being donors

(154).
Passive transfer of allergy:
Ramirez

~

tells of a recipient several weeks

following transfusion from a donor sensitive to horse
dander, who was then himself sensitive to horses.
Hendriok (29) tells or theee transmissions of allergy
aeoidentally by transfusion.

Therefore, donors should

always be questioned regarding allergy and asthma.
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